Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-15

Clinical Trial Update: Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing buprenorphine to morphine for treating neonatal abstinence syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Morphine (morphine)
  • buprenorphine (buprenorphine)

Snippet

Sponsor: Pediatrix | Conditions: Neonatal Abstinence Syndrome, Neonatal Withdrawal Syndrome | Phase 2 | Status: COMPLETED